Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist.
暂无分享,去创建一个
D. Handley | R. Saunders | R. G. Van Valen | M. Melden | S. Flury | M. L. Lee | M. Lee | R. V. Van Valen
[1] D. Handley,et al. Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119. , 1986, Immunopharmacology.
[2] D. Handley,et al. Platelet activating factor and inflammation in atherogenesis: Targets for drug development , 1986 .
[3] D. Handley,et al. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig. , 1985, Thrombosis and haemostasis.
[4] P. Braquet,et al. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether. , 1985, Immunopharmacology.
[5] C. Galanos,et al. Distribution and localization of endotoxin in the reticulo-endothelial system (RES) and in the main vessels of the rat during shock. , 1985, Pathology, research and practice.
[6] S. Sumida,et al. Is platelet activating factor (PAF) a mediator of endotoxin shock? , 1985, European journal of pharmacology.
[7] J. Gomez-Cambronero,et al. Synthesis of PAF-acether and blood volume changes in gram-negative sepsis. , 1985, Immunopharmacology.
[8] D. Handley,et al. Effect of platelet activating factor on endothelial permeability to plasma macromolecules. , 1984, Immunopharmacology.
[9] D. Handley,et al. Evaluation of Dose and Route Effects of Platelet Activating Factor-Induced Extravasation in the Guinea Pig , 1984, Thrombosis and Haemostasis.
[10] T. Ono,et al. Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine. , 1984, European journal of pharmacology.
[11] Y. Kasuya,et al. Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF). , 1984, Journal of pharmacobio-dynamics.
[12] F. Snyder,et al. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone. , 1984, Circulatory shock.
[13] S. Ghosh,et al. Change in membrane lipid fluidity induced by phospholipase A activation: a mechanism of endotoxic shock. , 1983, Life sciences.
[14] G. Camussi,et al. The release of platelet-activating factor from human endothelial cells in culture. , 1983, Journal of immunology.
[15] R. N. Pinckard. Platelet-activating factor. , 1983, Hospital practice.
[16] S. Tanaka,et al. Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs. , 1983, Journal of pharmacobio-dynamics.
[17] W. Hsueh,et al. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. , 1983, The American journal of pathology.
[18] M. Sánchez-Crespo,et al. Platelet-activating factor: an effector substance of the vasopermeability changes induced by the infusion of immune aggregates in the mouse. , 1983, Immunopharmacology.
[19] J. Benveniste,et al. Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. , 1983, European journal of pharmacology.
[20] J. Egido,et al. Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. , 1982, Immunopharmacology.
[21] G. Camussi,et al. Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition. , 1982, Journal of immunology.
[22] L. W. Byers,et al. Alkyl Ether Analogs of Phosphatidylcholine Are Orally Active in Hypertensive Rabbits , 1981, Hypertension.
[23] F. Snyder,et al. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. , 1981, Biochimica et biophysica acta.
[24] G. Camussi,et al. Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. , 1981, Immunology.
[25] P. Ward,et al. Complement mediated inflammatory reactions. , 1981, Pathobiology annual.
[26] C. Redeuilh,et al. Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl choline , 1980, FEBS letters.
[27] D. Hanahan,et al. Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. , 1980, Biochimica et biophysica acta.
[28] F. Snyder,et al. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. , 1979, Biochemical and biophysical research communications.
[29] D. Hanahan,et al. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). , 1979, The Journal of biological chemistry.
[30] J. Cazenave,et al. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. , 1979, Laboratory investigation; a journal of technical methods and pathology.
[31] B. Vargaftig,et al. The role of platelet-activating factor in platelet aggregation , 1979, Nature.
[32] J. Mencia-Huerta,et al. Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes , 1979, European journal of immunology.
[33] T. Spector. Refinement of the Coomassie blue method of protein quantitation: A simple and linear spectrophotometric assay for ≤0.5 to 50 μg of protein , 1978 .
[34] P. Henson,et al. Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. , 1977, Journal of Immunology.
[35] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.